Hospital 9 De Octubre S.A.

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation2 trials
• Stroke2 trials
• Bladder cancer1 trial
• Deep vein thrombosis and pulmonary embolism1 trial
• Lung cancer1 trial
• Peripheral artery disease1 trial
• Prostate cancer1 trial

Phase

• Phase 35 trials
• Phase 41 trial

Status

• Not yet recruiting3 trials
• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• Regeneron Pharmaceuticals3 trials
• Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH1 trial
• Gilead Sciences1 trial
• Presurgy S.L.1 trial

Running trials

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

  NCT07626411· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease

  NCT07318610· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

  NCT07430956· Phase 3· Regeneron Pharmaceuticals· Source

• Recruiting

  [18F]PSMA-1007 PET CT in patients with newly-diagnosed prostate cancer

  2023-504026-19-01· Phase 3· Abx Advanced Biochemical Compounds - Biomedizinische Forschungsreagenzien GmbH· Source

• Active, not recruiting

  Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer

  NCT05502237· Phase 3· Gilead Sciences· Source

• Recruiting

  Study to evaluate the efficacy and safety of supportive mitomycin C administered via electric current in the treatment of non-muscle invasive bladder cancer versus the standard immunotherapy.

  2024-520006-19-00· Phase 4· Presurgy S.L.· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Atrial fibrillation2 recruiting
• Stroke2 recruiting
• Bladder cancer1 recruiting
• Deep vein thrombosis and pulmonary embolism1 recruiting
• Peripheral artery disease1 recruiting
• Prostate cancer1 recruiting